WR
www.rattanlifescience.com
The startup develops induced pluripotent stem cell (iPSC)-derived T cells for targeted immunotherapy in cancer and immune disorders. This technology provides a scalable solution for generating personalized T cell therapies, enhancing treatment efficacy and patient outcomes.
Traction –/10
HQ unknown
- Biotechnology
Updated 5 months ago
Funding
Funding rounds are not available yet.
Founders
Founder details are not available yet.
Product
Features
- The startup develops induced pluripotent stem cell (iPSC)-derived T cells for targeted immunotherapy in cancer and immune disorders. This technology provides a scalable solution for generating personalized T cell therapies, enhancing treatment efficacy and patient outcomes.